SBRT Technique Implementation for Spinal Metastases Irradiation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorInstitute of Oncology Ljubljana
About this trial
Stereotactic body radiotherapy (SBRT) is a highly precise, image-guided radiotherapy technique delivering 1-5 high-dose fractions to spinal metastases. Compared with conventional radiotherapy, SBRT enables delivery of a higher biologically effective dose while maintaining high precision.
The Institute of Oncology Ljubljana initiated spinal SBRT treatments in 2017 and introduced an institutional SBRT spine protocol in 2019. As SBRT is technically demanding, strict adherence to standardized planning and delivery procedures is essential to ensure treatment quality and patient safety.
This clinical program aims to support structured implementation and continuous development of the institutional SBRT spine protocol in routine clinical practice. The study prospectively evaluates treatment-related toxicity and local tumor control following SBRT for spinal metastases in order to monitor treatment safety and effectiveness within the institutional program.
Eligibility criteria
Qualifiers
Adult patients (≥18 years) with spinal metastases or spinal tumors referred for stereotactic body radiotherapy (SBRT).
Patients eligible for SBRT treatment according to the institutional SBRT spine protocol.
Ability to undergo CT simulation, immobilization, and image-guided radiotherapy procedures.
Disqualifiers
Inability to tolerate SBRT positioning or immobilization.
Clinical situations requiring urgent surgical intervention or alternative treatment.
Other medical conditions that prevent safe SBRT delivery.
Trial design
Treatments tested in this trial
- Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov